p21WAF1 and p53 immunohistochemical expression in breast carcinoma may predict therapeutic response to adjuvant treatment.
Barbareschi, M
p21WAF1 and p53 immunohistochemical expression in breast carcinoma may predict therapeutic response to adjuvant treatment. [electronic resource] - European journal of cancer (Oxford, England : 1990) Nov 1996 - 2182-3 p. digital
Publication Type: Letter
0959-8049
10.1016/s0959-8049(96)00222-5 doi
Biomarkers, Tumor--metabolism
Breast Neoplasms--drug therapy
Chemotherapy, Adjuvant
Cyclin-Dependent Kinase Inhibitor p21
Cyclins--metabolism
Female
Humans
Neoplasm Proteins--metabolism
Survival Rate
Tumor Suppressor Protein p53--metabolism
p21WAF1 and p53 immunohistochemical expression in breast carcinoma may predict therapeutic response to adjuvant treatment. [electronic resource] - European journal of cancer (Oxford, England : 1990) Nov 1996 - 2182-3 p. digital
Publication Type: Letter
0959-8049
10.1016/s0959-8049(96)00222-5 doi
Biomarkers, Tumor--metabolism
Breast Neoplasms--drug therapy
Chemotherapy, Adjuvant
Cyclin-Dependent Kinase Inhibitor p21
Cyclins--metabolism
Female
Humans
Neoplasm Proteins--metabolism
Survival Rate
Tumor Suppressor Protein p53--metabolism